Literature DB >> 21489988

Domain 3 of NS5A protein from the hepatitis C virus has intrinsic alpha-helical propensity and is a substrate of cyclophilin A.

Dries Verdegem1, Aurélie Badillo, Jean-Michel Wieruszeski, Isabelle Landrieu, Arnaud Leroy, Ralf Bartenschlager, François Penin, Guy Lippens, Xavier Hanoulle.   

Abstract

Nonstructural protein 5A (NS5A) is essential for hepatitis C virus (HCV) replication and constitutes an attractive target for antiviral drug development. Although structural data for its in-plane membrane anchor and domain D1 are available, the structure of domains 2 (D2) and 3 (D3) remain poorly defined. We report here a comparative molecular characterization of the NS5A-D3 domains of the HCV JFH-1 (genotype 2a) and Con1 (genotype 1b) strains. Combining gel filtration, CD, and NMR spectroscopy analyses, we show that NS5A-D3 is natively unfolded. However, NS5A-D3 domains from both JFH-1 and Con1 strains exhibit a propensity to partially fold into an α-helix. NMR analysis identifies two putative α-helices, for which a molecular model could be obtained. The amphipathic nature of the first helix and its conservation in all genotypes suggest that it might correspond to a molecular recognition element and, as such, promote the interaction with relevant biological partner(s). Because mutations conferring resistance to cyclophilin inhibitors have been mapped into NS5A-D3, we also investigated the functional interaction between NS5A-D3 and cyclophilin A (CypA). CypA indeed interacts with NS5A-D3, and this interaction is completely abolished by cyclosporin A. NMR heteronuclear exchange experiments demonstrate that CypA has in vitro peptidyl-prolyl cis/trans-isomerase activity toward some, but not all, of the peptidyl-prolyl bonds in NS5A-D3. These studies lead to novel insights into the structural features of NS5A-D3 and its relationships with CypA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21489988      PMCID: PMC3121464          DOI: 10.1074/jbc.M110.182436

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  76 in total

1.  Graphical interpretation of Boolean operators for protein NMR assignments.

Authors:  Dries Verdegem; Klaas Dijkstra; Xavier Hanoulle; Guy Lippens
Journal:  J Biomol NMR       Date:  2008-09-02       Impact factor: 2.835

2.  Prediction of disordered regions in proteins based on the meta approach.

Authors:  Takashi Ishida; Kengo Kinoshita
Journal:  Bioinformatics       Date:  2008-04-20       Impact factor: 6.937

3.  Suppression of hepatitis C virus replication by cyclosporin a is mediated by blockade of cyclophilins.

Authors:  Mina Nakagawa; Naoya Sakamoto; Yoko Tanabe; Tomoyuki Koyama; Yasuhiro Itsui; Yoshie Takeda; Cheng-Hsin Chen; Sei Kakinuma; Shinya Oooka; Shinya Maekawa; Nobuyuki Enomoto; Mamoru Watanabe
Journal:  Gastroenterology       Date:  2005-09       Impact factor: 22.682

4.  A heteronuclear correlation experiment for simultaneous determination of 15N longitudinal decay and chemical exchange rates of systems in slow equilibrium.

Authors:  N A Farrow; O Zhang; J D Forman-Kay; L E Kay
Journal:  J Biomol NMR       Date:  1994-09       Impact factor: 2.835

5.  Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro.

Authors:  Feng Yang; Jason M Robotham; Heather B Nelson; Andre Irsigler; Rachael Kenworthy; Hengli Tang
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

6.  Cyclophilin: a specific cytosolic binding protein for cyclosporin A.

Authors:  R E Handschumacher; M W Harding; J Rice; R J Drugge; D W Speicher
Journal:  Science       Date:  1984-11-02       Impact factor: 47.728

7.  Quantitative determination of helical propensities from trifluoroethanol titration curves.

Authors:  A Jasanoff; A R Fersht
Journal:  Biochemistry       Date:  1994-03-01       Impact factor: 3.162

8.  Mechanism of resistance of hepatitis C virus replicons to structurally distinct cyclophilin inhibitors.

Authors:  Xiaoling Puyang; Danielle L Poulin; Joanna E Mathy; Leah J Anderson; Sue Ma; Zheng Fang; Shejin Zhu; Kai Lin; Roger Fujimoto; Teresa Compton; Brigitte Wiedmann
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

9.  Identification of residues required for RNA replication in domains II and III of the hepatitis C virus NS5A protein.

Authors:  Timothy L Tellinghuisen; Katie L Foss; Jason C Treadaway; Charles M Rice
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

10.  Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles.

Authors:  Jieyun Jiang; Guangxiang Luo
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

View more
  50 in total

Review 1.  Anti-HCV drugs in the pipeline.

Authors:  Priscilla L Yang; Min Gao; Kai Lin; Qingsong Liu; Valerie A Villareal
Journal:  Curr Opin Virol       Date:  2011-11-13       Impact factor: 7.090

Review 2.  Chaperones in hepatitis C virus infection.

Authors:  Ronik Khachatoorian; Samuel W French
Journal:  World J Hepatol       Date:  2016-01-08

3.  Intrinsic disorder mediates hepatitis C virus core-host cell protein interactions.

Authors:  Patrick T Dolan; Andrew P Roth; Bin Xue; Ren Sun; A Keith Dunker; Vladimir N Uversky; Douglas J LaCount
Journal:  Protein Sci       Date:  2014-12-31       Impact factor: 6.725

4.  Cyclophilins facilitate dissociation of the human papillomavirus type 16 capsid protein L1 from the L2/DNA complex following virus entry.

Authors:  Malgorzata Bienkowska-Haba; Carlyn Williams; Seong Man Kim; Robert L Garcea; Martin Sapp
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

Review 5.  Hepatitis C virus-host interactions, replication, and viral assembly.

Authors:  Ana Shulla; Glenn Randall
Journal:  Curr Opin Virol       Date:  2012-10-18       Impact factor: 7.090

6.  Functional characterization of bovine viral diarrhea virus nonstructural protein 5A by reverse genetic analysis and live cell imaging.

Authors:  Olaf Isken; Ulrike Langerwisch; Robert Schönherr; Benjamin Lamp; Kristin Schröder; Rainer Duden; Tillmann H Rümenapf; Norbert Tautz
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

7.  Fluorescence resonance energy transfer-based intracellular assay for the conformation of hepatitis C virus drug target NS5A.

Authors:  Dipankar Bhattacharya; Israrul H Ansari; Andrew Mehle; Rob Striker
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

8.  Correlation between NS5A dimerization and hepatitis C virus replication.

Authors:  Precious J Lim; Udayan Chatterji; Daniel Cordek; Suresh D Sharma; Jose A Garcia-Rivera; Craig E Cameron; Kai Lin; Paul Targett-Adams; Philippe A Gallay
Journal:  J Biol Chem       Date:  2012-07-16       Impact factor: 5.157

9.  A conserved tandem cyclophilin-binding site in hepatitis C virus nonstructural protein 5A regulates Alisporivir susceptibility.

Authors:  Henry Grisé; Stephen Frausto; Timothy Logan; Hengli Tang
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

10.  HCV NS5A and IRF9 compete for CypA binding.

Authors:  Michael Bobardt; Sam Hopkins; James Baugh; Udayan Chatterji; Felicia Hernandez; John Hiscott; Ann Sluder; Kai Lin; Philippe A Gallay
Journal:  J Hepatol       Date:  2012-08-15       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.